The PE Ratio as of November 2024 (TTM) for BioMarin Pharmaceutical Inc. (BMRN) is 38.71

According to BioMarin Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 38.71. This represents a change of -54.10% compared to the average of 84.33 of the last 4 quarters.

BioMarin Pharmaceutical Inc. (BMRN) Historical PE Ratio (quarterly & annually)

How has BMRN PE Ratio performed in the past?

The mean historical PE Ratio of BioMarin Pharmaceutical Inc. over the last ten years is -117.06. The current 38.71 PE Ratio has changed -3406.72% with respect to the historical average. Over the past ten years (40 quarters), BMRN's PE Ratio was at its highest in in the June 2021 quarter at 294.73. The PE Ratio was at its lowest in in the December 2022 quarter at -19329.36.

BioMarin Pharmaceutical Inc. (BMRN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioMarin Pharmaceutical Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioMarin Pharmaceutical Inc. (BMRN) Average PE Ratio

How has BMRN PE Ratio performed in the past?

The current PE Ratio of BioMarin Pharmaceutical Inc. (BMRN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioMarin Pharmaceutical Inc. (BMRN) PE Ratio vs. Peers

How is BMRN’s PE Ratio compared to its peers?

BioMarin Pharmaceutical Inc.’s PE Ratio is greater than Seagen Inc. (-100.71), greater than Alnylam Pharmaceuticals, Inc. (-94.78), greater than Exelixis, Inc. (21.78), greater than Halozyme Therapeutics, Inc. (15.84), greater than Arrowhead Pharmaceuticals, Inc. (-4.27), less than Incyte Corporation (425.32), greater than Ionis Pharmaceuticals, Inc. (-14.08), greater than Apellis Pharmaceuticals, Inc. (-15.24), greater than Vaxcyte, Inc. (-21.57), greater than Liquidia Corporation (-6.98), greater than Legend Biotech Corporation (-21.42), less than Bio-Techne Corporation (74.98), greater than Mereo BioPharma Group plc (-13.56), greater than Blueprint Medicines Corporation (-46.60), greater than Agios Pharmaceuticals, Inc. (4.70), greater than Day One Biopharmaceuticals, Inc. (-15.73), greater than IVERIC bio, Inc. (-27.51), greater than Amylyx Pharmaceuticals, Inc. (-1.38), greater than Karuna Therapeutics, Inc. (-37.08),

Build a custom stock screener for BioMarin Pharmaceutical Inc. (BMRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMarin Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioMarin Pharmaceutical Inc. (BMRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioMarin Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.